Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites

• DOI: 10.3389/fphar.2024.1343755
• Publication Date: 2024-04-24T04:44:28Z
• Authors: Dongliang Chen; Yuanfei Wang; Jianmei Yang; Wanyi Ou; Guiru Lin; Ze Zeng; Xiaomin Lu; Zumin Chen; Lili Zou; Yaling Tian; Aiping Wu; Shelley E. Keating; Qinhe Yang; Chenli Lin; Yinji Liang
• Keywords: Gut–brain axis

The prevalence of non-alcoholic fatty liver disease (NAFLD) and its related mortality is increasing at an unprecedented rate. Traditional Chinese medicine (TCM) has been shown to offer potential for early prevention treatment NAFLD. new mechanism "Shenling Baizhu San" (SLBZS) examined in this study the NAFLD preclinical level.